Mark Geyer - Publications

University of California, San Diego, La Jolla, CA 

308 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Barnes SA, Dillon DG, Young JW, Thomas ML, Faget L, Yoo JH, Der-Avakian A, Hnasko TS, Geyer MA, Ramanathan DS. Modulation of ventromedial orbitofrontal cortical glutamatergic activity affects the explore-exploit balance and influences value-based decision-making. Cerebral Cortex (New York, N.Y. : 1991). PMID 36472411 DOI: 10.1093/cercor/bhac459  0.409
2022 Ayoub S, Kenton JA, Milienne-Petiot M, Deben DS, Achim C, Geyer MA, Perry W, Grant IE, Young JW, Minassian A. iTat transgenic mice exhibit hyper-locomotion in the behavioral pattern monitor after chronic exposure to methamphetamine but are unaffected by Tat expression. Pharmacology, Biochemistry, and Behavior. 222: 173499. PMID 36462584 DOI: 10.1016/j.pbb.2022.173499  0.492
2022 Acheson DT, Baker DG, Nievergelt CM, Yurgil KA, Geyer MA, Risbrough VB. Prospective longitudinal assessment of sensorimotor gating as a risk/resiliency factor for posttraumatic stress disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 36192631 DOI: 10.1038/s41386-022-01460-9  0.506
2022 Young JW, Kenton JA, Milienne-Petiot M, Deben D, Achim C, Geyer MA, Perry W, Grant IE, Minassian A. Chronic methamphetamine exposure exerts few effects on the iTat mouse model of HIV, but blocks Tat expression-induced slowed reward retrieval. Behavioural Brain Research. 437: 114109. PMID 36108778 DOI: 10.1016/j.bbr.2022.114109  0.439
2021 Roberts BZ, Minassian A, Halberstadt AL, He YV, Chatha M, Geyer MA, Grant I, Young JW. HIV transgenic rats demonstrate impaired sensorimotor gating, but are insensitive to cannabinoid (Δ9-tetrahydrocannabinol)-induced deficits. The International Journal of Neuropsychopharmacology. PMID 34338765 DOI: 10.1093/ijnp/pyab053  0.664
2021 Nakamura M, Ye K, E Silva MB, Yamauchi T, Hoeppner DJ, Fayyazuddin A, Kang G, Yuda EA, Nagashima M, Enomoto S, Hiramoto T, Sharp R, Kaneko I, Tajinda K, Adachi M, ... ... Geyer MA, et al. Computational identification of variables in neonatal vocalizations predictive for postpubertal social behaviors in a mouse model of 16p11.2 deletion. Molecular Psychiatry. PMID 33859357 DOI: 10.1038/s41380-021-01089-y  0.508
2021 Cope ZA, Kenton JA, Minassian A, Martin MV, Perry W, Bundgaard C, Arnt J, van Enkhuizen J, Geyer MA, Young JW. Chronic antipsychotic treatment exerts limited effects on the mania-like behavior of dopamine transporter knockdown mice. Behavioural Brain Research. 113167. PMID 33577882 DOI: 10.1016/j.bbr.2021.113167  0.762
2020 Jordan Walter T, Pocuca N, Young JW, Geyer MA, Minassian A, Perry W. The relationship between cannabis use and cognition in people with bipolar disorder: A systematic scoping review. Psychiatry Research. 297: 113695. PMID 33545431 DOI: 10.1016/j.psychres.2020.113695  0.402
2020 Pocuca N, Walter TJ, Minassian A, Young JW, Geyer MA, Perry W. The Effects of Cannabis Use on Cognitive Function in Healthy Aging: A Systematic Scoping Review. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. PMID 33159510 DOI: 10.1093/arclin/acaa105  0.37
2020 Pocuca N, Young JW, MacQueen DA, Letendre S, Heaton RK, Geyer MA, Perry W, Grant I, Minassian A. Sustained attention and vigilance deficits associated with HIV and a history of methamphetamine dependence. Drug and Alcohol Dependence. 215: 108245. PMID 32871507 DOI: 10.1016/J.Drugalcdep.2020.108245  0.375
2020 Huckins LM, Chatzinakos C, Breen MS, Hartmann J, Klengel T, da Silva Almeida AC, Dobbyn A, Girdhar K, Hoffman GE, Klengel C, Logue MW, Lori A, Maihofer AX, Morrison FG, Nguyen HT, ... ... Geyer MA, et al. Analysis of Genetically Regulated Gene Expression Identifies a Prefrontal PTSD Gene, SNRNP35, Specific to Military Cohorts. Cell Reports. 31: 107716. PMID 32492425 DOI: 10.1016/J.Celrep.2020.107716  0.491
2019 Young JW, Geyer MA, Halberstadt AL, van Enkhuizen J, Minassian A, Khan A, Perry W, Eyler LT. Convergent neural substrates of inattention in bipolar disorder patients and dopamine transporter-deficient mice using the 5-choice CPT. Bipolar Disorders. PMID 31025493 DOI: 10.1111/Bdi.12786  0.759
2018 Halberstadt AL, van der Zee JVF, Chatha M, Geyer MA, Powell SB. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen. Psychopharmacology. PMID 30448990 DOI: 10.1007/S00213-018-5118-Y  0.744
2018 Milienne-Petiot M, Higa KK, Grim A, Deben D, Groenink L, Twamley EW, Geyer MA, Young JW. Nicotine improves probabilistic reward learning in wildtype but not alpha7 nAChR null mutants, yet alpha7 nAChR agonists do not improve probabilistic learning. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30213668 DOI: 10.1016/J.Euroneuro.2018.08.005  0.425
2018 MacQueen DA, Minassian A, Kenton JA, Geyer MA, Perry W, Brigman JL, Young JW. Amphetamine improves mouse and human attention in the 5-choice continuous performance test. Neuropharmacology. PMID 29859849 DOI: 10.1016/J.Neuropharm.2018.05.034  0.464
2018 Minassian A, Young JW, Geyer MA, Kelsoe JR, Perry W. The COMT Val158Met Polymorphism and Exploratory Behavior in Bipolar Mania. Molecular Neuropsychiatry. 3: 151-156. PMID 29594134 DOI: 10.1159/000481822  0.453
2018 Phillips AG, Geyer MA, Robbins TW. Effective Use of Animal Models for Therapeutic Development in Psychiatric and Substance Use Disorders. Biological Psychiatry. PMID 29478700 DOI: 10.1016/j.biopsych.2018.01.014  0.352
2018 Stout DM, Acheson DT, Moore TM, Gur RC, Baker DG, Geyer MA, Risbrough VB. Individual variation in working memory is associated with fear extinction performance. Behaviour Research and Therapy. 102: 52-59. PMID 29331727 DOI: 10.1016/J.Brat.2018.01.002  0.484
2017 Kwiatkowski MA, Hellemann G, Sugar CA, Cope ZA, Minassian A, Perry W, Geyer MA, Young JW. Dopamine transporter knockdown mice in the behavioral pattern monitor: A robust, reproducible model for mania-relevant behaviors. Pharmacology, Biochemistry, and Behavior. PMID 29289701 DOI: 10.1016/J.Pbb.2017.12.007  0.774
2017 MacQueen DA, Minassian A, Henry BL, Geyer MA, Young JW, Perry W. Amphetamine Modestly Improves Conners' Continuous Performance Test Performance in Healthy Adults. Journal of the International Neuropsychological Society : Jins. 1-11. PMID 29032769 DOI: 10.1017/S135561771700090X  0.41
2017 Deslauriers J, Acheson DT, Maihofer AX, Nievergelt CM, Baker DG, Geyer MA, Risbrough VB. COMT val158met polymorphism links to altered fear conditioning and extinction are modulated by PTSD and childhood trauma. Depression and Anxiety. PMID 28833952 DOI: 10.1002/Da.22678  0.488
2017 Cope ZA, Minassian A, Kreitner D, MacQueen DA, Milienne-Petiot M, Geyer MA, Perry W, Young JW. Modafinil improves attentional performance in healthy, non-sleep deprived humans at doses not inducing hyperarousal across species. Neuropharmacology. PMID 28774856 DOI: 10.1016/J.Neuropharm.2017.07.031  0.763
2017 Nolte IM, Munoz ML, Tragante V, Amare AT, Jansen R, Vaez A, von der Heyde B, Avery CL, Bis JC, Dierckx B, van Dongen J, Gogarten SM, Goyette P, Hernesniemi J, Huikari V, ... ... Geyer MA, et al. Erratum: Genetic loci associated with heart rate variability and their effects on cardiac disease risk. Nature Communications. 8: 16140. PMID 28767105 DOI: 10.1038/Ncomms16140  0.454
2017 Nolte IM, Munoz ML, Tragante V, Amare AT, Jansen R, Vaez A, von der Heyde B, Avery CL, Bis JC, Dierckx B, van Dongen J, Gogarten SM, Goyette P, Hernesniemi J, Huikari V, ... ... Geyer MA, et al. Genetic loci associated with heart rate variability and their effects on cardiac disease risk. Nature Communications. 8: 15805. PMID 28613276 DOI: 10.1038/Ncomms15805  0.462
2017 Glenn DE, Acheson DT, Geyer MA, Nievergelt CM, Baker DG, Risbrough VB. Fear learning alterations after traumatic brain injury and their role in development of posttraumatic stress symptoms. Depression and Anxiety. PMID 28489272 DOI: 10.1002/Da.22642  0.483
2017 Higa KK, Grim A, Kamenski ME, van Enkhuizen J, Zhou X, Li K, Naviaux JC, Wang L, Naviaux RK, Geyer MA, Markou A, Young JW. Nicotine withdrawal-induced inattention is absent in alpha7 nAChR knockout mice. Psychopharmacology. PMID 28243714 DOI: 10.1007/S00213-017-4572-2  0.42
2017 Halberstadt AL, Geyer MA. Effect of Hallucinogens on Unconditioned Behavior. Current Topics in Behavioral Neurosciences. PMID 28224459 DOI: 10.1007/7854_2016_466  0.641
2017 Milienne-Petiot M, Geyer MA, Arnt J, Young JW. Brexpiprazole reduces hyperactivity, impulsivity, and risk-preference behavior in mice with dopamine transporter knockdown-a model of mania. Psychopharmacology. PMID 28160035 DOI: 10.1007/S00213-017-4543-7  0.46
2017 Deslauriers J, van Wijngaarde M, Geyer MA, Powell S, Risbrough VB. Effects of LPS-induced immune activation prior to trauma exposure on PTSD-like symptoms in mice. Behavioural Brain Research. PMID 28159589 DOI: 10.1016/J.Bbr.2017.01.048  0.695
2017 Higa KK, Young JW, Ji B, Nichols DE, Geyer MA, Zhou X. Striatal dopamine D1 receptor suppression impairs reward-associative learning. Behavioural Brain Research. PMID 28143767 DOI: 10.1016/J.Bbr.2017.01.041  0.438
2017 Young J, Graves M, Milienne-Petiot M, Nichols D, Twamley E, Geyer M. SA113. Dopamine D1 Receptor Activation Improves Reward-Associative Learning in a Mouse Probabilistic Learning Task Schizophrenia Bulletin. 43: S153-S154. DOI: 10.1093/Schbul/Sbx023.111  0.484
2017 Cope Z, Minassian A, Kreitner D, MacQueen D, Miliene-Petiot M, Geyer M, Perry W, Young J. M113. Modafinil Improves Continuous Task Performance in Healthy, Non-Sleep Deprived Humans at Doses Not Inducing Hyperarousal Across Species Schizophrenia Bulletin. 43: S251-S252. DOI: 10.1093/Schbul/Sbx022.108  0.731
2017 Deslauriers J, Esders M, Maihofer A, Nievergelt C, Baker D, Geyer M, Risbrough V. M93. No Association Between COMT Val158Met and Prepulse Inhibition: Findings From the Marine Resiliency Study Schizophrenia Bulletin. 43. DOI: 10.1093/Schbul/Sbx022.088  0.528
2017 Risbrough V, Geyer M, Acheson D, Minassian A, Maihofer A, Baker D, Nievergelt C. 88. Identification of Psychophysiological Markers of PTSD Risk and Potential Use as Intermediate Phenotypes Biological Psychiatry. 81: S37. DOI: 10.1016/J.Biopsych.2017.02.100  0.512
2016 Ahmari SE, Risbrough VB, Geyer MA, Simpson HB. Prepulse Inhibition Deficits in Obsessive-Compulsive Disorder are More Pronounced in Females. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 41: 2963-2964. PMID 27818517 DOI: 10.1038/Npp.2015.363  0.514
2016 Milienne-Petiot M, Kesby JP, Graves M, van Enkhuizen J, Semenova S, Minassian A, Markou A, Geyer MA, Young JW. The effects of reduced dopamine transporter function and chronic lithium on motivation, probabilistic learning, and neurochemistry in mice: Modeling bipolar mania. Neuropharmacology. PMID 27732870 DOI: 10.1016/J.Neuropharm.2016.07.030  0.477
2016 Cope ZA, Halberstadt AL, van Enkhuizen J, Flynn AD, Breier M, Swerdlow NR, Geyer MA, Young JW. Premature responses in the five-choice serial reaction time task reflect rodents' temporal strategies: evidence from no-light and pharmacological challenges. Psychopharmacology. PMID 27534540 DOI: 10.1007/S00213-016-4389-4  0.774
2016 Young JW, Minassian A, Geyer MA. Locomotor Profiling from Rodents to the Clinic and Back Again. Current Topics in Behavioral Neurosciences. PMID 27418071 DOI: 10.1007/7854_2015_5015  0.495
2016 Halberstadt AL, Sindhunata I, Scheffers K, Flynn AD, Sharp RF, Geyer MA, Young JW. Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice. Neuropharmacology. PMID 27020041 DOI: 10.1016/J.Neuropharm.2016.03.038  0.716
2016 Steinman SA, Ahmari SE, Choo T, Kimeldorf MB, Feit R, Loh S, Risbrough V, Geyer MA, Steinglass JE, Wall M, Schneier FR, Fyer AJ, Simpson HB. PREPULSE INHIBITION DEFICITS ONLY IN FEMALES WITH OBSESSIVE-COMPULSIVE DISORDER. Depression and Anxiety. 33: 238-46. PMID 26878422 DOI: 10.1002/Da.22474  0.544
2016 Higa KK, Young JW, Geyer MA. Wet or dry: translatable "water mazes" for mice and humans. The Journal of Clinical Investigation. 1-3. PMID 26784538 DOI: 10.1172/Jci86071  0.408
2016 Geyer M, Halberstadt A. Behavioural and pharmacological studies of pharmahuasca in rodents European Neuropsychopharmacology. 26: S120. DOI: 10.1016/S0924-977X(16)30889-6  0.578
2015 Toth M, Flandreau EI, Deslauriers J, Geyer MA, Mansuy I, Merlo-Pich E, Risbrough V. Overexpression of Forebrain CRH During Early Life Increases Trauma Susceptibility in Adulthood. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26538448 DOI: 10.1038/Npp.2015.338  0.778
2015 Minassian A, Young JW, Cope ZA, Henry BL, Geyer MA, Perry W. Amphetamine increases activity but not exploration in humans and mice. Psychopharmacology. PMID 26449721 DOI: 10.1007/S00213-015-4098-4  0.772
2015 Minassian A, Maihofer AX, Baker DG, Nievergelt CM, Geyer MA, Risbrough VB. Association of Predeployment Heart Rate Variability With Risk of Postdeployment Posttraumatic Stress Disorder in Active-Duty Marines. Jama Psychiatry. 1-8. PMID 26353072 DOI: 10.1001/jamapsychiatry.2015.0922  0.481
2015 van Enkhuizen J, Geyer MA, Minassian A, Perry W, Henry BL, Young JW. Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies. Neuroscience and Biobehavioral Reviews. PMID 26297513 DOI: 10.1016/J.Neubiorev.2015.08.008  0.47
2015 van Enkhuizen J, Milienne-Petiot M, Geyer MA, Young JW. Modeling bipolar disorder in mice by increasing acetylcholine or dopamine: chronic lithium treats most, but not all features. Psychopharmacology. 232: 3455-67. PMID 26141192 DOI: 10.1007/S00213-015-4000-4  0.442
2015 Higa KK, Ji B, Buell MR, Risbrough VB, Powell SB, Young JW, Geyer MA, Zhou X. Restoration of Sp4 in Forebrain GABAergic Neurons Rescues Hypersensitivity to Ketamine in Sp4 Hypomorphic Mice. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26037489 DOI: 10.1093/Ijnp/Pyv063  0.766
2015 Powell SB, Khan A, Young JW, Scott CN, Buell MR, Caldwell S, Tsan E, de Jong LA, Acheson DT, Lucero J, Geyer MA, Behrens MM. Early Adolescent Emergence of Reversal Learning Impairments in Isolation-Reared Rats. Developmental Neuroscience. PMID 26022788 DOI: 10.1159/000430091  0.768
2015 Young JW, Kamenski ME, Higa KK, Light GA, Geyer MA, Zhou X. GlyT-1 Inhibition Attenuates Attentional But Not Learning or Motivational Deficits of the Sp4 Hypomorphic Mouse Model Relevant to Psychiatric Disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 25907107 DOI: 10.1038/Npp.2015.120  0.496
2015 Yurgil KA, Clifford RE, Risbrough VB, Geyer MA, Huang M, Barkauskas DA, Vasterling JJ, Baker DG. Prospective Associations Between Traumatic Brain Injury and Postdeployment Tinnitus in Active-Duty Marines. The Journal of Head Trauma Rehabilitation. PMID 25699623 DOI: 10.1097/Htr.0000000000000117  0.465
2015 Flandreau E, Risbrough V, Lu A, Ableitner M, Geyer MA, Holsboer F, Deussing JM. Cell type-specific modifications of corticotropin-releasing factor (CRF) and its type 1 receptor (CRF1) on startle behavior and sensorimotor gating. Psychoneuroendocrinology. 53: 16-28. PMID 25575243 DOI: 10.1016/J.Psyneuen.2014.12.005  0.796
2015 Young JW, Geyer MA. Developing treatments for cognitive deficits in schizophrenia: the challenge of translation. Journal of Psychopharmacology (Oxford, England). 29: 178-96. PMID 25516372 DOI: 10.1177/0269881114555252  0.529
2015 Nievergelt CM, Maihofer AX, Mustapic M, Yurgil KA, Schork NJ, Miller MW, Logue MW, Geyer MA, Risbrough VB, O'Connor DT, Baker DG. Genomic predictors of combat stress vulnerability and resilience in U.S. Marines: A genome-wide association study across multiple ancestries implicates PRTFDC1 as a potential PTSD gene. Psychoneuroendocrinology. 51: 459-71. PMID 25456346 DOI: 10.1016/j.psyneuen.2014.10.017  0.481
2015 Acheson DT, Geyer MA, Baker DG, Nievergelt CM, Yurgil K, Risbrough VB. Conditioned fear and extinction learning performance and its association with psychiatric symptoms in active duty Marines. Psychoneuroendocrinology. 51: 495-505. PMID 25444643 DOI: 10.1016/J.Psyneuen.2014.09.030  0.501
2015 van Enkhuizen J, Janowsky DS, Olivier B, Minassian A, Perry W, Young JW, Geyer MA. The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited. European Journal of Pharmacology. 753: 114-26. PMID 25107282 DOI: 10.1016/J.Ejphar.2014.05.063  0.451
2015 Van Enkhuizen J, Geyer MA, Kooistra K, Young JW. Chronic valproate attenuates some, but not ail, facets of mania-like behaviour in mice | Chronische behandeling met valproïnezuur verzwakt sommige, maar niet alle facetten van manie-achtig gedrag bij muizen Pharmaceutisch Weekblad. 150: 102-111.  0.442
2014 Acheson DT, Geyer MA, Risbrough VB. Psychophysiology in the study of psychological trauma: where are we now and where do we need to be? Current Topics in Behavioral Neurosciences. 21: 157-83. PMID 25158622 DOI: 10.1007/7854_2014_346  0.481
2014 van Enkhuizen J, Henry BL, Minassian A, Perry W, Milienne-Petiot M, Higa KK, Geyer MA, Young JW. Reduced dopamine transporter functioning induces high-reward risk-preference consistent with bipolar disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 3112-22. PMID 25005251 DOI: 10.1038/Npp.2014.170  0.453
2014 Ji B, Higa KK, Kim M, Zhou L, Young JW, Geyer MA, Zhou X. Inhibition of protein translation by the DISC1-Boymaw fusion gene from a Scottish family with major psychiatric disorders. Human Molecular Genetics. 23: 5683-705. PMID 24908665 DOI: 10.1093/Hmg/Ddu285  0.457
2014 Minassian A, Geyer MA, Baker DG, Nievergelt CM, O'Connor DT, Risbrough VB. Heart rate variability characteristics in a large group of active-duty marines and relationship to posttraumatic stress. Psychosomatic Medicine. 76: 292-301. PMID 24804881 DOI: 10.1097/PSY.0000000000000056  0.48
2014 Csomor PA, Preller KH, Geyer MA, Studerus E, Huber T, Vollenweider FX. Influence of aripiprazole, risperidone, and amisulpride on sensory and sensorimotor gating in healthy 'low and high gating' humans and relation to psychometry. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 2485-96. PMID 24801767 DOI: 10.1038/Npp.2014.102  0.519
2014 Young JW, Ratty A, Dawe GS, Geyer MA. Altered exploration and sensorimotor gating of the chakragati mouse model of schizophrenia. Behavioral Neuroscience. 128: 460-7. PMID 24708299 DOI: 10.1037/A0036425  0.525
2014 van Enkhuizen J, Acheson D, Risbrough V, Drummond S, Geyer MA, Young JW. Sleep deprivation impairs performance in the 5-choice continuous performance test: similarities between humans and mice. Behavioural Brain Research. 261: 40-8. PMID 24333377 DOI: 10.1016/J.Bbr.2013.12.003  0.628
2014 Toth M, Gresack JE, Bangasser DA, Plona Z, Valentino RJ, Flandreau EI, Mansuy IM, Merlo-Pich E, Geyer MA, Risbrough VB. Forebrain-specific CRF overproduction during development is sufficient to induce enduring anxiety and startle abnormalities in adult mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1409-19. PMID 24326400 DOI: 10.1038/Npp.2013.336  0.796
2014 van Enkhuizen J, Geyer MA, Halberstadt AL, Zhuang X, Young JW. Dopamine depletion attenuates some behavioral abnormalities in a hyperdopaminergic mouse model of bipolar disorder. Journal of Affective Disorders. 155: 247-54. PMID 24287168 DOI: 10.1016/J.Jad.2013.08.041  0.723
2014 Henry BL, Geyer MA, Buell MR, Perry W, Young JW, Minassian A. Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine. Behavioural Pharmacology. 25: 12-22. PMID 24281153 DOI: 10.1097/Fbp.0000000000000012  0.471
2014 Halberstadt AL, Geyer MA. Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response. Neuropharmacology. 77: 200-7. PMID 24012658 DOI: 10.1016/J.Neuropharm.2013.08.025  0.622
2014 Amitai N, Young JW, Higa K, Sharp RF, Geyer MA, Powell SB. Isolation rearing effects on probabilistic learning and cognitive flexibility in rats. Cognitive, Affective & Behavioral Neuroscience. 14: 388-406. PMID 23943516 DOI: 10.3758/S13415-013-0204-4  0.696
2013 Young JW, Geyer MA, Rissling AJ, Sharp RF, Eyler LT, Asgaard GL, Light GA. Reverse translation of the rodent 5C-CPT reveals that the impaired attention of people with schizophrenia is similar to scopolamine-induced deficits in mice. Translational Psychiatry. 3: e324. PMID 24217494 DOI: 10.1038/Tp.2013.82  0.513
2013 Halberstadt AL, Geyer MA. Serotonergic hallucinogens as translational models relevant to schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 2165-80. PMID 23942028 DOI: 10.1017/S1461145713000722  0.631
2013 Young JW, Geyer MA. Evaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia. Biochemical Pharmacology. 86: 1122-32. PMID 23856289 DOI: 10.1016/J.Bcp.2013.06.031  0.474
2013 Ji B, Wang X, Pinto-Duarte A, Kim M, Caldwell S, Young JW, Behrens MM, Sejnowski TJ, Geyer MA, Zhou X. Prolonged Ketamine Effects in Sp4 Hypomorphic Mice: Mimicking Phenotypes of Schizophrenia. Plos One. 8: e66327. PMID 23823008 DOI: 10.1371/Journal.Pone.0066327  0.501
2013 Henry BL, Minassian A, Patt VM, Hua J, Young JW, Geyer MA, Perry W. Inhibitory deficits in euthymic bipolar disorder patients assessed in the human behavioral pattern monitor. Journal of Affective Disorders. 150: 948-54. PMID 23759280 DOI: 10.1016/J.Jad.2013.05.020  0.482
2013 Liu X, Hong SI, Park SJ, Dela Peña JB, Che H, Yoon SY, Kim DH, Kim JM, Cai M, Risbrough V, Geyer MA, Shin CY, Cheong JH, Park H, Lew JH, et al. The ameliorating effects of 5,7-dihydroxy-6-methoxy-2(4-phenoxyphenyl)-4H-chromene-4-one, an oroxylin A derivative, against memory impairment and sensorimotor gating deficit in mice. Archives of Pharmacal Research. 36: 854-63. PMID 23543630 DOI: 10.1007/S12272-013-0106-6  0.579
2013 Halberstadt AL, Geyer MA. Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement. Psychopharmacology. 227: 727-39. PMID 23407781 DOI: 10.1007/S00213-013-3006-Z  0.613
2013 Halberstadt AL, Powell SB, Geyer MA. Role of the 5-HTâ‚‚A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice. Neuropharmacology. 70: 218-27. PMID 23376711 DOI: 10.1016/J.Neuropharm.2013.01.014  0.761
2013 Young JW, Meves JM, Geyer MA. Nicotinic agonist-induced improvement of vigilance in mice in the 5-choice continuous performance test. Behavioural Brain Research. 240: 119-33. PMID 23201359 DOI: 10.1016/J.Bbr.2012.11.028  0.463
2013 van Enkhuizen J, Geyer MA, Kooistra K, Young JW. Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 1021-31. PMID 23164454 DOI: 10.1017/S1461145712001198  0.51
2013 Holstein DH, Vollenweider FX, Geyer MA, Csomor PA, Belser N, Eich D. Sensory and sensorimotor gating in adult attention-deficit/hyperactivity disorder (ADHD). Psychiatry Research. 205: 117-26. PMID 23017654 DOI: 10.1016/J.Psychres.2012.08.013  0.514
2013 Henry BL, Geyer MA, Buell M, Perry W, Young JW, Minassian A. Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice. Behavioural Brain Research. 236: 210-20. PMID 22960458 DOI: 10.1016/J.Bbr.2012.08.037  0.472
2013 van Enkhuizen J, Geyer MA, Young JW. Differential effects of dopamine transporter inhibitors in the rodent Iowa gambling task: relevance to mania. Psychopharmacology. 225: 661-74. PMID 22945515 DOI: 10.1007/S00213-012-2854-2  0.514
2013 Halberstadt AL, Geyer MA. Neuropharmacology of Lysergic Acid Diethylamide (LSD) and Other Hallucinogens Biological Research On Addiction. 625-635. DOI: 10.1016/B978-0-12-398335-0.00061-3  0.53
2012 Young JW, Amitai N, Geyer MA. Behavioral animal models to assess pro-cognitive treatments for schizophrenia. Handbook of Experimental Pharmacology. 39-79. PMID 23027412 DOI: 10.1007/978-3-642-25758-2_3  0.457
2012 Ayalew M, Le-Niculescu H, Levey DF, Jain N, Changala B, Patel SD, Winiger E, Breier A, Shekhar A, Amdur R, Koller D, Nurnberger JI, Corvin A, Geyer M, Tsuang MT, et al. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Molecular Psychiatry. 17: 887-905. PMID 22584867 DOI: 10.1038/Mp.2012.37  0.332
2012 Baker DG, Nash WP, Litz BT, Geyer MA, Risbrough VB, Nievergelt CM, O'Connor DT, Larson GE, Schork NJ, Vasterling JJ, Hammer PS, Webb-Murphy JA. Predictors of risk and resilience for posttraumatic stress disorder among ground combat Marines: methods of the Marine Resiliency Study. Preventing Chronic Disease. 9: E97. PMID 22575082 DOI: 10.5888/pcd9.110134  0.472
2012 Acheson DT, Stein MB, Paulus MP, Geyer MA, Risbrough VB. The effect of pregabalin on sensorimotor gating in 'low' gating humans and mice. Neuropharmacology. 63: 480-5. PMID 22575075 DOI: 10.1016/J.Neuropharm.2012.04.018  0.702
2012 Swerdlow NR, Light GA, Breier MR, Shoemaker JM, Saint Marie RL, Neary AC, Geyer MA, Stevens KE, Powell SB. Sensory and sensorimotor gating deficits after neonatal ventral hippocampal lesions in rats. Developmental Neuroscience. 34: 240-9. PMID 22572564 DOI: 10.1159/000336841  0.621
2012 Tanaka S, Young JW, Halberstadt AL, Masten VL, Geyer MA. Four factors underlying mouse behavior in an open field. Behavioural Brain Research. 233: 55-61. PMID 22569582 DOI: 10.1016/J.Bbr.2012.04.045  0.673
2012 Halberstadt AL, Buell MR, Price DL, Geyer MA. Differences in the locomotor-activating effects of indirect serotonin agonists in habituated and non-habituated rats. Pharmacology, Biochemistry, and Behavior. 102: 88-94. PMID 22487771 DOI: 10.1016/J.Pbb.2012.03.023  0.694
2012 Powell SB, Weber M, Geyer MA. Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders. Current Topics in Behavioral Neurosciences. 12: 251-318. PMID 22367921 DOI: 10.1007/7854_2011_195  0.619
2012 Halberstadt AL, Nichols DE, Geyer MA. Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor. Psychopharmacology. 221: 709-18. PMID 22222861 DOI: 10.1007/S00213-011-2616-6  0.632
2012 Ahmari SE, Risbrough VB, Geyer MA, Simpson HB. Impaired sensorimotor gating in unmedicated adults with obsessive-compulsive disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1216-23. PMID 22218093 DOI: 10.1038/Npp.2011.308  0.545
2012 Quednow BB, Kometer M, Geyer MA, Vollenweider FX. Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 630-40. PMID 21956447 DOI: 10.1038/Npp.2011.228  0.551
2012 Young JW, Powell SB, Geyer MA. Mouse pharmacological models of cognitive disruption relevant to schizophrenia. Neuropharmacology. 62: 1381-90. PMID 21726569 DOI: 10.1016/J.Neuropharm.2011.06.013  0.689
2012 Risbrough V, Baker DG, Nievergelt C, Litz B, Nash W, Perez J, Geyer M. Prospective assessment of psychophysiological risk factors for PTSD European Journal of Psychotraumatology. 3. DOI: 10.3402/Ejpt.V3I0.19473  0.504
2012 Young JW, Kamenski ME, Geyer MA. Poster #222 DELAYED “EUREKA” OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR KNOCKOUT MICE IN A PROBABILISTIC REVERSAL LEARNING PARADIGM Schizophrenia Research. 136: S361. DOI: 10.1016/S0920-9964(12)71054-X  0.423
2011 Minassian A, Henry BL, Young JW, Masten V, Geyer MA, Perry W. Repeated assessment of exploration and novelty seeking in the human behavioral pattern monitor in bipolar disorder patients and healthy individuals. Plos One. 6: e24185. PMID 21912623 DOI: 10.1371/Journal.Pone.0024185  0.465
2011 Holstein DH, Csomor PA, Geyer MA, Huber T, Brugger N, Studerus E, Vollenweider FX. The effects of sertindole on sensory gating, sensorimotor gating, and cognition in healthy volunteers. Journal of Psychopharmacology (Oxford, England). 25: 1600-13. PMID 21890590 DOI: 10.1177/0269881111415734  0.55
2011 Tanaka S, Young JW, Gresack JE, Geyer MA, Risbrough VB. Factor analysis of attentional set-shifting performance in young and aged mice. Behavioral and Brain Functions : Bbf. 7: 33. PMID 21838910 DOI: 10.1186/1744-9081-7-33  0.622
2011 Chung S, Verheij MM, Hesseling P, van Vugt RW, Buell M, Belluzzi JD, Geyer MA, Martens GJ, Civelli O. The melanin-concentrating hormone (MCH) system modulates behaviors associated with psychiatric disorders. Plos One. 6: e19286. PMID 21818251 DOI: 10.1371/Journal.Pone.0019286  0.345
2011 Young JW, Meves JM, Tarantino IS, Caldwell S, Geyer MA. Delayed procedural learning in α7-nicotinic acetylcholine receptor knockout mice. Genes, Brain, and Behavior. 10: 720-33. PMID 21679297 DOI: 10.1111/J.1601-183X.2011.00711.X  0.491
2011 Carter CS, Barch DM, Bullmore E, Breiling J, Buchanan RW, Butler P, Cohen JD, Geyer M, Gollub R, Green MF, Jaeger J, Krystal JH, Moore H, Nuechterlein K, Robbins T, et al. Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disorders. Biological Psychiatry. 70: 7-12. PMID 21529781 DOI: 10.1016/J.Biopsych.2011.01.041  0.44
2011 Young JW, Powell SB, Scott CN, Zhou X, Geyer MA. The effect of reduced dopamine D4 receptor expression in the 5-choice continuous performance task: Separating response inhibition from premature responding. Behavioural Brain Research. 222: 183-92. PMID 21458500 DOI: 10.1016/J.Bbr.2011.03.054  0.73
2011 Young JW, van Enkhuizen J, Winstanley CA, Geyer MA. Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania. Journal of Psychopharmacology (Oxford, England). 25: 934-43. PMID 21421642 DOI: 10.1177/0269881111400646  0.499
2011 Young JW, Kooistra K, Geyer MA. Dopamine receptor mediation of the exploratory/hyperactivity effects of modafinil. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 1385-96. PMID 21412225 DOI: 10.1038/Npp.2011.23  0.547
2011 Young JW, Henry BL, Geyer MA. Predictive animal models of mania: hits, misses and future directions. British Journal of Pharmacology. 164: 1263-84. PMID 21410454 DOI: 10.1111/J.1476-5381.2011.01318.X  0.436
2011 Henry BL, Minassian A, van Rhenen M, Young JW, Geyer MA, Perry W. Effect of methamphetamine dependence on inhibitory deficits in a novel human open-field paradigm. Psychopharmacology. 215: 697-707. PMID 21279333 DOI: 10.1007/S00213-011-2170-2  0.456
2011 Halberstadt AL, Geyer MA. Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology. 61: 364-81. PMID 21256140 DOI: 10.1016/J.Neuropharm.2011.01.017  0.626
2011 Tarantino IS, Sharp RF, Geyer MA, Meves JM, Young JW. Working memory span capacity improved by a D2 but not D1 receptor family agonist. Behavioural Brain Research. 219: 181-8. PMID 21232557 DOI: 10.1016/J.Bbr.2010.12.037  0.493
2011 Halberstadt AL, Lehmann-Masten VD, Geyer MA, Powell SB. Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice. Psychopharmacology. 215: 81-92. PMID 21153406 DOI: 10.1007/S00213-010-2115-1  0.764
2011 Halberstadt AL, Koedood L, Powell SB, Geyer MA. Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice. Journal of Psychopharmacology (Oxford, England). 25: 1548-61. PMID 21148021 DOI: 10.1177/0269881110388326  0.74
2011 Ali SS, Young JW, Wallace CK, Gresack J, Jeste DV, Geyer MA, Dugan LL, Risbrough VB. Initial evidence linking synaptic superoxide production with poor short-term memory in aged mice. Brain Research. 1368: 65-70. PMID 21075081 DOI: 10.1016/J.Brainres.2010.11.009  0.662
2011 Young JW, Geyer MA. Using behavioral patterns across species in mood disorder research Neuromethods. 63: 21-41. DOI: 10.1007/978-1-61779-313-4_2  0.413
2010 Young JW, Zhou X, Geyer MA. Animal models of schizophrenia. Current Topics in Behavioral Neurosciences. 4: 391-433. PMID 21312408 DOI: 10.1007/7854_2010_62  0.484
2010 Semenova S, Hoyer D, Geyer MA, Markou A. Somatostatin-28 modulates prepulse inhibition of the acoustic startle response, reward processes and spontaneous locomotor activity in rats. Neuropeptides. 44: 421-9. PMID 20537385 DOI: 10.1016/J.Npep.2010.04.008  0.324
2010 Young JW, Powell SB, Geyer MA, Jeste DV, Risbrough VB. The mouse attentional-set-shifting task: a method for assaying successful cognitive aging? Cognitive, Affective & Behavioral Neuroscience. 10: 243-51. PMID 20498348 DOI: 10.3758/Cabn.10.2.243  0.767
2010 Perry W, Minassian A, Henry B, Kincaid M, Young JW, Geyer MA. Quantifying over-activity in bipolar and schizophrenia patients in a human open field paradigm. Psychiatry Research. 178: 84-91. PMID 20471103 DOI: 10.1016/J.Psychres.2010.04.032  0.453
2010 Gresack J, Powell S, Geyer M, Poore MS, Coste S, Risbrough V. CRF2 null mutation increases sensitivity to isolation rearing effects on locomotor activity in mice. Neuropeptides. 44: 349-53. PMID 20466421 DOI: 10.1016/J.Npep.2010.04.005  0.752
2010 Henry BL, Minassian A, Young JW, Paulus MP, Geyer MA, Perry W. Cross-species assessments of motor and exploratory behavior related to bipolar disorder. Neuroscience and Biobehavioral Reviews. 34: 1296-306. PMID 20398694 DOI: 10.1016/J.Neubiorev.2010.04.002  0.647
2010 Young JW, Goey AK, Minassian A, Perry W, Paulus MP, Geyer MA. The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration. Pharmacology, Biochemistry, and Behavior. 96: 7-15. PMID 20363246 DOI: 10.1016/J.Pbb.2010.03.014  0.688
2010 Chang WL, Geyer MA, Buell MR, Weber M, Swerdlow NR. The effects of pramipexole on prepulse inhibition and locomotor activity in C57BL/6J mice. Behavioural Pharmacology. 21: 135-43. PMID 20215963 DOI: 10.1097/Fbp.0B013E328337Be7E  0.312
2010 Young JW, Wallace CK, Geyer MA, Risbrough VB. Age-associated improvements in cross-modal prepulse inhibition in mice. Behavioral Neuroscience. 124: 133-40. PMID 20141288 DOI: 10.1037/A0018462  0.639
2010 Young JW, Geyer MA. Action of modafinil--increased motivation via the dopamine transporter inhibition and D1 receptors? Biological Psychiatry. 67: 784-7. PMID 20132929 DOI: 10.1016/J.Biopsych.2009.12.015  0.531
2010 Gresack JE, Risbrough VB, Scott CN, Coste S, Stenzel-Poore M, Geyer MA, Powell SB. Isolation rearing-induced deficits in contextual fear learning do not require CRF(2) receptors. Behavioural Brain Research. 209: 80-4. PMID 20097235 DOI: 10.1016/J.Bbr.2010.01.018  0.728
2010 Young JW, Goey AK, Minassian A, Perry W, Paulus MP, Geyer MA. GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior. Psychopharmacology. 208: 443-54. PMID 20020109 DOI: 10.1007/S00213-009-1744-8  0.705
2010 Hilti CC, Delko T, Orosz AT, Thomann K, Ludewig S, Geyer MA, Vollenweider FX, Feldon J, Cattapan-Ludewig K. Sustained attention and planning deficits but intact attentional set-shifting in neuroleptic-naïve first-episode schizophrenia patients. Neuropsychobiology. 61: 79-86. PMID 20016226 DOI: 10.1159/000265133  0.52
2010 Halberstadt AL, Geyer MA. LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor. Psychopharmacology. 208: 179-89. PMID 19937319 DOI: 10.1007/S00213-009-1718-X  0.622
2010 Henry BL, Minassian A, Paulus MP, Geyer MA, Perry W. Heart rate variability in bipolar mania and schizophrenia. Journal of Psychiatric Research. 44: 168-76. PMID 19700172 DOI: 10.1016/j.jpsychires.2009.07.011  0.535
2010 Minassian A, Henry BL, Geyer MA, Paulus MP, Young JW, Perry W. The quantitative assessment of motor activity in mania and schizophrenia. Journal of Affective Disorders. 120: 200-6. PMID 19435640 DOI: 10.1016/J.Jad.2009.04.018  0.618
2010 Geyer MA, Nichols DE, Vollenweider FX. Serotonin-related psychedelic drugs Encyclopedia of Neuroscience. 731-738. DOI: 10.1016/B978-008045046-9.01160-8  0.459
2009 Ruderman MA, Powell SB, Geyer MA. A Kappa Opioid Model of Atypical Altered Consciousness and Psychosis: U50488, DOI, AC90179 Effects on Prepulse Inhibition and Locomotion in Mice. Journal of Young Investigators. 19: 1-7. PMID 25346645  0.629
2009 Perry W, Minassian A, Paulus MP, Young JW, Kincaid MJ, Ferguson EJ, Henry BL, Zhuang X, Masten VL, Sharp RF, Geyer MA. A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Archives of General Psychiatry. 66: 1072-80. PMID 19805697 DOI: 10.1001/Archgenpsychiatry.2009.58  0.681
2009 Suzuki G, Harper KM, Hiramoto T, Funke B, Lee M, Kang G, Buell M, Geyer MA, Kucherlapati R, Morrow B, Männistö PT, Agatsuma S, Hiroi N. Over-expression of a human chromosome 22q11.2 segment including TXNRD2, COMT and ARVCF developmentally affects incentive learning and working memory in mice. Human Molecular Genetics. 18: 3914-25. PMID 19617637 DOI: 10.1093/Hmg/Ddp334  0.546
2009 Duvvuri V, Risbrough VB, Kaye WH, Geyer MA. 5-HT1A receptor activation is necessary for 5-MeODMT-dependent potentiation of feeding inhibition. Pharmacology, Biochemistry, and Behavior. 93: 349-53. PMID 19490926 DOI: 10.1016/J.Pbb.2009.05.014  0.565
2009 Marston HM, Young JW, Martin FD, Serpa KA, Moore CL, Wong EH, Gold L, Meltzer LT, Azar MR, Geyer MA, Shahid M. Asenapine effects in animal models of psychosis and cognitive function. Psychopharmacology. 206: 699-714. PMID 19462162 DOI: 10.1007/S00213-009-1570-Z  0.469
2009 Powell SB, Zhou X, Geyer MA. Prepulse inhibition and genetic mouse models of schizophrenia. Behavioural Brain Research. 204: 282-94. PMID 19397931 DOI: 10.1016/J.Bbr.2009.04.021  0.622
2009 Halberstadt AL, van der Heijden I, Ruderman MA, Risbrough VB, Gingrich JA, Geyer MA, Powell SB. 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1958-67. PMID 19322172 DOI: 10.1038/Npp.2009.29  0.788
2009 Young JW, Powell SB, Risbrough V, Marston HM, Geyer MA. Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacology & Therapeutics. 122: 150-202. PMID 19269307 DOI: 10.1016/J.Pharmthera.2009.02.004  0.74
2009 Suzuki G, Harper KM, Hiramoto T, Sawamura T, Lee M, Kang G, Tanigaki K, Buell M, Geyer MA, Trimble WS, Agatsuma S, Hiroi N. Sept5 deficiency exerts pleiotropic influence on affective behaviors and cognitive functions in mice. Human Molecular Genetics. 18: 1652-60. PMID 19240081 DOI: 10.1093/Hmg/Ddp086  0.557
2009 Young JW, Light GA, Marston HM, Sharp R, Geyer MA. The 5-choice continuous performance test: evidence for a translational test of vigilance for mice. Plos One. 4: e4227. PMID 19156216 DOI: 10.1371/Journal.Pone.0004227  0.447
2009 Barch DM, Carter CS, Arnsten A, Buchanan RW, Cohen JD, Geyer M, Green MF, Krystal JH, Nuechterlein K, Robbins T, Silverstein S, Smith EE, Strauss M, Wykes T, Heinssen R. Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting. Schizophrenia Bulletin. 35: 109-14. PMID 19023126 DOI: 10.1093/Schbul/Sbn163  0.412
2009 Risbrough VB, Geyer MA, Hauger RL, Coste S, Stenzel-Poore M, Wurst W, Holsboer F. CRF1 and CRF2 receptors are required for potentiated startle to contextual but not discrete cues. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1494-503. PMID 19020499 DOI: 10.1038/Npp.2008.205  0.573
2009 Shanahan NA, Holick Pierz KA, Masten VL, Waeber C, Ansorge M, Gingrich JA, Geyer MA, Hen R, Dulawa SC. Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice. Biological Psychiatry. 65: 401-8. PMID 19013555 DOI: 10.1016/J.Biopsych.2008.09.026  0.812
2009 Halberstadt AL, Geyer MA. Habituation and sensitization of acoustic startle: opposite influences of dopamine D1 and D2-family receptors. Neurobiology of Learning and Memory. 92: 243-8. PMID 18644244 DOI: 10.1016/J.Nlm.2008.05.015  0.657
2009 Tanaka S, Risbrough V, Young J, Gresack J, Geyer M. N-factor models of cognitive and behavioral functions of aged and young mice Neuroscience Research. 65: S117. DOI: 10.1016/J.Neures.2009.09.546  0.66
2008 Geyer MA, Vollenweider FX. Serotonin research: contributions to understanding psychoses. Trends in Pharmacological Sciences. 29: 445-53. PMID 19086254 DOI: 10.1016/J.Tips.2008.06.006  0.563
2008 Powell SB, Young JW, Ong JC, Caron MG, Geyer MA. Atypical antipsychotics clozapine and quetiapine attenuate prepulse inhibition deficits in dopamine transporter knockout mice. Behavioural Pharmacology. 19: 562-5. PMID 18690110 DOI: 10.1097/Fbp.0B013E32830Dc110  0.73
2008 Halberstadt AL, Buell MR, Masten VL, Risbrough VB, Geyer MA. Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors. Psychopharmacology. 201: 55-66. PMID 18604652 DOI: 10.1007/S00213-008-1247-Z  0.736
2008 Carter CS, Barch DM, Buchanan RW, Bullmore E, Krystal JH, Cohen J, Geyer M, Green M, Nuechterlein KH, Robbins T, Silverstein S, Smith EE, Strauss M, Wykes T, Heinssen R. Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative. Biological Psychiatry. 64: 4-10. PMID 18466880 DOI: 10.1016/J.Biopsych.2008.03.020  0.427
2008 Le-Niculescu H, McFarland MJ, Ogden CA, Balaraman Y, Patel S, Tan J, Rodd ZA, Paulus M, Geyer MA, Edenberg HJ, Glatt SJ, Faraone SV, Nurnberger JI, Kuczenski R, Tsuang MT, et al. Phenomic, convergent functional genomic, and biomarker studies in a stress-reactive genetic animal model of bipolar disorder and co-morbid alcoholism. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 147: 134-66. PMID 18247375 DOI: 10.1002/Ajmg.B.30707  0.548
2008 Doherty JM, Masten VL, Powell SB, Ralph RJ, Klamer D, Low MJ, Geyer MA. Contributions of dopamine D1, D2, and D3 receptor subtypes to the disruptive effects of cocaine on prepulse inhibition in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 2648-56. PMID 18075489 DOI: 10.1038/Sj.Npp.1301657  0.812
2008 Jonkman S, Risbrough VB, Geyer MA, Markou A. Spontaneous nicotine withdrawal potentiates the effects of stress in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 2131-8. PMID 18033237 DOI: 10.1038/Sj.Npp.1301607  0.519
2008 Csomor PA, Stadler RR, Feldon J, Yee BK, Geyer MA, Vollenweider FX. Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 497-512. PMID 17460616 DOI: 10.1038/Sj.Npp.1301421  0.545
2008 Risbrough VB, Geyer MA. Preclinical Approaches to Understanding Anxiety Disorders Oxford Handbook of Anxiety and Related Disorders. DOI: 10.1093/oxfordhb/9780195307030.013.0007  0.477
2007 Powell SB, Geyer MA. Overview of animal models of schizophrenia. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 9.24. PMID 18428667 DOI: 10.1002/0471142301.Ns0924S39  0.617
2007 Young JW, Minassian A, Paulus MP, Geyer MA, Perry W. A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor. Neuroscience and Biobehavioral Reviews. 31: 882-96. PMID 17706782 DOI: 10.1016/J.Neubiorev.2007.05.009  0.673
2007 Harte MK, Powell SB, Swerdlow NR, Geyer MA, Reynolds GP. Deficits in parvalbumin and calbindin immunoreactive cells in the hippocampus of isolation reared rats. Journal of Neural Transmission (Vienna, Austria : 1996). 114: 893-8. PMID 17594127 DOI: 10.1007/S00702-007-0627-6  0.612
2007 Vinkers CH, Risbrough VB, Geyer MA, Caldwell S, Low MJ, Hauger RL. Role of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gating. Pharmacology, Biochemistry, and Behavior. 86: 550-8. PMID 17324452 DOI: 10.1016/J.Pbb.2007.01.018  0.59
2007 Vollenweider FX, Csomor PA, Knappe B, Geyer MA, Quednow BB. The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 1876-87. PMID 17299516 DOI: 10.1038/Sj.Npp.1301324  0.569
2006 Risbrough VB, Masten VL, Caldwell S, Paulus MP, Low MJ, Geyer MA. Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2349-58. PMID 16855533 DOI: 10.1038/Sj.Npp.1301161  0.71
2006 Barr AM, Powell SB, Markou A, Geyer MA. Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats. Neuropharmacology. 51: 457-65. PMID 16762376 DOI: 10.1016/J.Neuropharm.2006.04.004  0.659
2006 Vanover KE, Weiner DM, Makhay M, Veinbergs I, Gardell LR, Lameh J, Del Tredici AL, Piu F, Schiffer HH, Ott TR, Burstein ES, Uldam AK, Thygesen MB, Schlienger N, Andersson CM, ... ... Geyer MA, et al. Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonist. The Journal of Pharmacology and Experimental Therapeutics. 317: 910-8. PMID 16469866 DOI: 10.1124/Jpet.105.097006  0.623
2006 Postma P, Gray JA, Sharma T, Geyer M, Mehrotra R, Das M, Zachariah E, Hines M, Williams SC, Kumari V. A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia. Psychopharmacology. 184: 589-99. PMID 16456657 DOI: 10.1007/S00213-006-0307-5  0.321
2006 Varty GB, Powell SB, Lehmann-Masten V, Buell MR, Geyer MA. Isolation rearing of mice induces deficits in prepulse inhibition of the startle response. Behavioural Brain Research. 169: 162-7. PMID 16406103 DOI: 10.1016/J.Bbr.2005.11.025  0.77
2005 Ong JC, Brody SA, Large CH, Geyer MA. An investigation of the efficacy of mood stabilizers in rodent models of prepulse inhibition. The Journal of Pharmacology and Experimental Therapeutics. 315: 1163-71. PMID 16123308 DOI: 10.1124/Jpet.105.090845  0.734
2005 Brody SA, Nakanishi N, Tu S, Lipton SA, Geyer MA. A developmental influence of the N-methyl-D-aspartate receptor NR3A subunit on prepulse inhibition of startle. Biological Psychiatry. 57: 1147-52. PMID 15866554 DOI: 10.1016/J.Biopsych.2005.01.024  0.666
2005 Powell SB, Palomo J, Carasso BS, Bakshi VP, Geyer MA. Yohimbine disrupts prepulse inhibition in rats via action at 5-HT1A receptors, not alpha2-adrenoceptors. Psychopharmacology. 180: 491-500. PMID 15719216 DOI: 10.1007/S00213-005-2193-7  0.759
2005 Ludewig S, Geyer MA, Ramseier M, Vollenweider FX, Rechsteiner E, Cattapan-Ludewig K. Information-processing deficits and cognitive dysfunction in panic disorder. Journal of Psychiatry & Neuroscience : Jpn. 30: 37-43. PMID 15644996  0.476
2005 Risbrough VB, Geyer MA. Anxiogenic treatments do not increase fear-potentiated startle in mice. Biological Psychiatry. 57: 33-43. PMID 15607298 DOI: 10.1016/j.biopsych.2004.10.006  0.548
2005 Erhardt S, Powell S, Nilsson L, Linderholm K, Swerdlow N, Geyer M. P.2.05. Rats reared in social isolation displaydisrupted ppi and elevated levels of kynurenic acid in the hippocampus European Neuropsychopharmacology. 15: S34-S35. DOI: 10.1016/S0924-977X(05)80145-2  0.562
2004 Ogden CA, Rich ME, Schork NJ, Paulus MP, Geyer MA, Lohr JB, Kuczenski R, Niculescu AB. Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Molecular Psychiatry. 9: 1007-29. PMID 15314610 DOI: 10.1038/Sj.Mp.4001547  0.519
2004 Harte MK, Powell SB, Reynolds LM, Swerdlow NR, Geyer MA, Reynolds GP. Reduced N-acetylaspartate in the temporal cortex of rats reared in isolation. Biological Psychiatry. 56: 296-9. PMID 15312819 DOI: 10.1016/J.Biopsych.2004.06.009  0.608
2004 Erhardt S, Schwieler L, Emanuelsson C, Geyer M. Endogenous kynurenic acid disrupts prepulse inhibition. Biological Psychiatry. 56: 255-60. PMID 15312813 DOI: 10.1016/j.biopsych.2004.06.006  0.403
2004 Risbrough VB, Hauger RL, Roberts AL, Vale WW, Geyer MA. Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 6545-52. PMID 15269266 DOI: 10.1523/JNEUROSCI.5760-03.2004  0.565
2004 Powell SB, Geyer MA, Gallagher D, Paulus MP. The balance between approach and avoidance behaviors in a novel object exploration paradigm in mice. Behavioural Brain Research. 152: 341-9. PMID 15196802 DOI: 10.1016/J.Bbr.2003.10.020  0.709
2004 Brody SA, Geyer MA. Interactions of the mGluR5 gene with breeding and maternal factors on startle and prepulse inhibition in mice. Neurotoxicity Research. 6: 79-90. PMID 15184109 DOI: 10.1007/Bf03033300  0.726
2004 Powell SB, Lehmann-Masten VD, Paulus MP, Gainetdinov RR, Caron MG, Geyer MA. MDMA "ecstasy" alters hyperactive and perseverative behaviors in dopamine transporter knockout mice. Psychopharmacology. 173: 310-7. PMID 14747902 DOI: 10.1007/S00213-003-1765-7  0.744
2004 Brody SA, Dulawa SC, Conquet F, Geyer MA. Assessment of a prepulse inhibition deficit in a mutant mouse lacking mGlu5 receptors. Molecular Psychiatry. 9: 35-41. PMID 14699440 DOI: 10.1038/  0.804
2004 Brody SA, Conquet F, Geyer MA. Effect of antipsychotic treatment on the prepulse inhibition deficit of mGluR5 knockout mice. Psychopharmacology. 172: 187-95. PMID 14615875 DOI: 10.1007/s00213-003-1635-3  0.741
2004 Barr AM, Lehmann-Masten V, Paulus M, Gainetdinov RR, Caron MG, Geyer MA. The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 221-8. PMID 14603268 DOI: 10.1038/Sj.Npp.1300343  0.633
2004 Harte M, Powell S, Reynolds L, Geyer M, Reynolds G. S.4.05 Reduced N-acetyl aspartate levels in the temporal cortex of rats reared in isolation European Neuropsychopharmacology. 14: S66-S67. DOI: 10.1016/S0924-977X(04)90083-1  0.565
2004 Geyer M, Brody S, Conquet F. S.08.05 Group I mGIuR receptors in rodent models for schizophrenia European Neuropsychopharmacology. 14: S130. DOI: 10.1016/S0924-977X(04)80032-4  0.685
2003 Geyer MA, Dulawa SC. Assessment of murine startle reactivity, prepulse inhibition, and habituation. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 8.17. PMID 18428584 DOI: 10.1002/0471142301.ns0817s24  0.656
2003 Brody SA, Conquet F, Geyer MA. Disruption of prepulse inhibition in mice lacking mGluR1. The European Journal of Neuroscience. 18: 3361-6. PMID 14686909 DOI: 10.1111/j.1460-9568.2003.03073.x  0.731
2003 Harvey PD, Geyer MA, Robbins TW, Krystal JH. Cognition in schizophrenia: from basic science to clinical treatment. Psychopharmacology. 169: 213-4. PMID 12955286 DOI: 10.1007/S00213-003-1581-0  0.376
2003 Ludewig K, Geyer MA, Vollenweider FX. Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia. Biological Psychiatry. 54: 121-8. PMID 12873801 DOI: 10.1016/S0006-3223(02)01925-X  0.549
2003 Ludewig K, Ludewig S, Seitz A, Obrist M, Geyer MA, Vollenweider FX. The acoustic startle reflex and its modulation: effects of age and gender in humans. Biological Psychology. 63: 311-23. PMID 12853174 DOI: 10.1016/S0301-0511(03)00074-7  0.49
2003 Risbrough VB, Hauger RL, Pelleymounter MA, Geyer MA. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice. Psychopharmacology. 170: 178-87. PMID 12845406 DOI: 10.1007/s00213-003-1535-6  0.558
2003 Powell SB, Geyer MA, Preece MA, Pitcher LK, Reynolds GP, Swerdlow NR. Dopamine depletion of the nucleus accumbens reverses isolation-induced deficits in prepulse inhibition in rats. Neuroscience. 119: 233-40. PMID 12763084 DOI: 10.1016/S0306-4522(03)00122-2  0.625
2003 Brody SA, Geyer MA, Large CH. Lamotrigine prevents ketamine but not amphetamine-induced deficits in prepulse inhibition in mice. Psychopharmacology. 169: 240-6. PMID 12698229 DOI: 10.1007/S00213-003-1421-2  0.743
2003 Risbrough VB, Brodkin JD, Geyer MA. GABA-A and 5-HT1A receptor agonists block expression of fear-potentiated startle in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 654-63. PMID 12655310 DOI: 10.1038/sj.npp.1300079  0.563
2003 Powell SB, Paulus MP, Hartman DS, Godel T, Geyer MA. RO-10-5824 is a selective dopamine D4 receptor agonist that increases novel object exploration in C57 mice. Neuropharmacology. 44: 473-81. PMID 12646284 DOI: 10.1016/S0028-3908(02)00412-4  0.761
2003 Ralph-Williams RJ, Paulus MP, Zhuang X, Hen R, Geyer MA. Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system. Biological Psychiatry. 53: 352-9. PMID 12586455 DOI: 10.1016/S0006-3223(02)01489-0  0.605
2003 Powell SB, Risbrough VB, Geyer MA. Potential use of animal models to examine antipsychotic prophylaxis for schizophrenia Clinical Neuroscience Research. 3: 289-296. DOI: 10.1016/S1566-2772(03)00089-6  0.716
2002 Powell SB, Geyer MA. Developmental markers of psychiatric disorders as identified by sensorimotor gating. Neurotoxicity Research. 4: 489-502. PMID 12754162 DOI: 10.1080/10298420290030578  0.645
2002 Vollenweider FX, Liechti ME, Gamma A, Greer G, Geyer M. Acute psychological and neurophysiological effects of MDMA in humans. Journal of Psychoactive Drugs. 34: 171-84. PMID 12691207 DOI: 10.1080/02791072.2002.10399951  0.575
2002 Ralph-Williams RJ, Lehmann-Masten V, Otero-Corchon V, Low MJ, Geyer MA. Differential effects of direct and indirect dopamine agonists on prepulse inhibition: a study in D1 and D2 receptor knock-out mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 9604-11. PMID 12417685 DOI: 10.1523/Jneurosci.22-21-09604.2002  0.332
2002 Powell SB, Swerdlow NR, Pitcher LK, Geyer MA. Isolation rearing-induced deficits in prepulse inhibition and locomotor habituation are not potentiated by water deprivation. Physiology & Behavior. 77: 55-64. PMID 12213502 DOI: 10.1016/S0031-9384(02)00817-X  0.622
2002 Ludewig K, Geyer MA, Etzensberger M, Vollenweider FX. Stability of the acoustic startle reflex, prepulse inhibition, and habituation in schizophrenia. Schizophrenia Research. 55: 129-37. PMID 11955972 DOI: 10.1016/S0920-9964(01)00198-0  0.517
2002 Ludewig S, Ludewig K, Geyer MA, Hell D, Vollenweider FX. Prepulse inhibition deficits in patients with panic disorder. Depression and Anxiety. 15: 55-60. PMID 11891993 DOI: 10.1002/Da.10026  0.496
2002 Martinez-Price D, Krebs-Thomson K, Geyer M. Behavioral Psychopharmacology of MDMA and MDMA-Like Drugs: A Review of Human and Animal Studies Addiction Research & Theory. 10: 43-67. DOI: 10.1080/16066350290001704  0.331
2001 Vollenweider FX, Geyer MA. A systems model of altered consciousness: integrating natural and drug-induced psychoses. Brain Research Bulletin. 56: 495-507. PMID 11750795 DOI: 10.1016/S0361-9230(01)00646-3  0.565
2001 Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology. 156: 117-54. PMID 11549216 DOI: 10.1007/s002130100811  0.305
2001 Ralph RJ, Paulus MP, Geyer MA. Strain-specific effects of amphetamine on prepulse inhibition and patterns of locomotor behavior in mice. The Journal of Pharmacology and Experimental Therapeutics. 298: 148-55. PMID 11408536  0.809
2001 Liechti ME, Geyer MA, Hell D, Vollenweider FX. Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 24: 240-52. PMID 11166515 DOI: 10.1016/S0893-133X(00)00199-8  0.567
2001 Ralph RJ, Paulus MP, Fumagalli F, Caron MG, Geyer MA. Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 305-13. PMID 11150348 DOI: 10.1523/Jneurosci.21-01-00305.2001  0.812
2001 Vollenweider F, Bächle D, Ludewig K, Geyer M, Hell D. Brain activation patterns of prepulse inhibition in humans: A [H2 15O]PET study European Neuropsychopharmacology. 11: S359-S360. DOI: 10.1016/S0924-977X(01)80544-7  0.514
2001 Ludewig S, Ludewig K, Geyer M, Hell D, Vollenweider F. Deficient prepulse inhibition of the acoustic startle reflex in panic disorder European Neuropsychopharmacology. 11: S312. DOI: 10.1016/S0924-977X(01)80434-X  0.552
2000 Dulawa SC, Geyer MA. Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice. Neuropharmacology. 39: 2170-9. PMID 10963760 DOI: 10.1016/S0028-3908(00)00030-7  0.67
2000 Palmer AA, Dulawa SC, Mottiwala AA, Conti LH, Geyer MA, Printz MP. Prepulse startle deficit in the Brown Norway rat: a potential genetic model. Behavioral Neuroscience. 114: 374-88. PMID 10832798 DOI: 10.1037/0735-7044.114.2.374  0.642
2000 Dulawa SC, Scearce-Levie KA, Hen R, Geyer MA. Serotonin releasers increase prepulse inhibition in serotonin 1B knockout mice. Psychopharmacology. 149: 306-12. PMID 10823412 DOI: 10.1007/s002130000373  0.68
2000 Varty GB, Paulus MP, Braff DL, Geyer MA. Environmental enrichment and isolation rearing in the rat: effects on locomotor behavior and startle response plasticity. Biological Psychiatry. 47: 864-73. PMID 10807959 DOI: 10.1016/S0006-3223(99)00269-3  0.736
2000 Dulawa SC, Gross C, Stark KL, Hen R, Geyer MA. Knockout mice reveal opposite roles for serotonin 1A and 1B receptors in prepulse inhibition. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 650-9. PMID 10788764 DOI: 10.1016/S0893-133X(99)00164-5  0.657
2000 Paulus MP, Varty GB, Geyer MA. The genetic liability to stress and postweaning isolation have a competitive influence on behavioral organization in rats. Physiology & Behavior. 68: 389-94. PMID 10716550 DOI: 10.1016/S0031-9384(99)00193-6  0.726
2000 Vollenweider F, Liechti M, Geyer M, Hell D. S30.02 Effects of MDMA (ecstasy) on sensorimotor gating (prepulse inhibition) in humans after pretreatment with citalopram, haloperidol, or ketanserin European Psychiatry. 15: 273s-273s. DOI: 10.1016/S0924-9338(00)94183-X  0.56
2000 Vollenweider F, Umbricht D, Geyer M, Hell D. Effects of NMDA-antagonists and 5-HT2A-agonists on prepulse inhibition in human volunteers Schizophrenia Research. 41: 147. DOI: 10.1016/S0920-9964(00)90657-1  0.557
2000 Ludewig K, Etzensberger M, Geyer M, Vollenweider F. 512. Stability of prepulse inhibition of the acoustic startle reflex in schizophrenia Biological Psychiatry. 47: S155. DOI: 10.1016/S0006-3223(00)00782-4  0.512
2000 Liechti M, Geyer M, Hell D, Vollenweider F. 485. MDMA (“ecstasy”) effects on sensorimotor gating after selective pretreatments in humans Biological Psychiatry. 47: S148. DOI: 10.1016/S0006-3223(00)00755-1  0.518
2000 Geyer M, Dulawa S, Ralph R, Henry S. 405. Startle habituation and prepulse inhibition studies in mutant mice Biological Psychiatry. 47: S124. DOI: 10.1016/S0006-3223(00)00675-2  0.788
1999 Dulawa SC, Grandy DK, Low MJ, Paulus MP, Geyer MA. Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 9550-6. PMID 10531457 DOI: 10.1523/Jneurosci.19-21-09550.1999  0.764
1999 Bakshi VP, Geyer MA. Ontogeny of isolation rearing-induced deficits in sensorimotor gating in rats Physiology and Behavior. 67: 385-392. PMID 10497957 DOI: 10.1016/S0031-9384(99)00082-7  0.688
1999 Bakshi VP, Geyer MA. Alpha-1-adrenergic receptors mediate sensorimotor gating deficits produced by intracerebral dizocilpine administration in rats Neuroscience. 92: 113-121. PMID 10392835 DOI: 10.1016/S0306-4522(98)00752-0  0.693
1999 Vollenweider FX, Remensberger S, Hell D, Geyer MA. Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans. Psychopharmacology. 143: 365-72. PMID 10367553 DOI: 10.1007/S002130050960  0.559
1999 Ralph RJ, Varty GB, Kelly MA, Wang YM, Caron MG, Rubinstein M, Grandy DK, Low MJ, Geyer MA. The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 4627-33. PMID 10341260 DOI: 10.1523/Jneurosci.19-11-04627.1999  0.801
1999 Varty GB, Braff DL, Geyer MA. Is there a critical developmental 'window' for isolation rearing-induced changes in prepulse inhibition of the acoustic startle response? Behavioural Brain Research. 100: 177-83. PMID 10212065 DOI: 10.1016/S0166-4328(98)00129-6  0.645
1999 Grailhe R, Waeber C, Dulawa SC, Hornung JP, Zhuang X, Brunner D, Geyer MA, Hen R. Increased exploratory activity and altered response to LSD in mice lacking the 5-HT(5A) receptor. Neuron. 22: 581-91. PMID 10197537 DOI: 10.1016/S0896-6273(00)80712-6  0.677
1999 Varty GB, Bakshi VP, Geyer MA. M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 20: 311-21. PMID 10088132 DOI: 10.1016/S0893-133X(98)00072-4  0.786
1999 Paulus MP, Geyer MA, Braff DL. Long-range correlations in choice sequences of schizophrenic patients. Schizophrenia Research. 35: 69-75. PMID 9988842 DOI: 10.1016/S0920-9964(98)00108-X  0.529
1999 Dulawa SC, Grandy DK, Low MJ, Paulus MP, Geyer MA. Dopamine D4 Receptor-Knock-Out Mice Exhibit Reduced Exploration of Novel Stimuli The Journal of Neuroscience. 19: 9550-9556. DOI: 10.1523/JNEUROSCI.19-21-09550.1999  0.751
1999 Vollenweider F, Liechti M, Gamma A, Geyer M, Hell D. Opposite effects of 3,4-methylenedioxy-methamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans European Neuropsychopharmacology. 9: 238-239. DOI: 10.1016/S0924-977X(99)80201-6  0.504
1999 Geyer MA, Krebs-Thomson K, Varty GB. The effects of M100907 in pharmacological and developmental animal models of prepulse inhibition deficits in schizophrenia Neuropsychopharmacology. 21: S134-S142. DOI: 10.1016/S0893-133X(99)00123-2  0.648
1998 Dulawa SC, Hen R, Scearce-Levie K, Geyer MA. 5-HT1B receptor modulation of prepulse inhibition: recent findings in wild-type and 5-HT1B knockout mice. Annals of the New York Academy of Sciences. 861: 79-84. PMID 9928242 DOI: 10.1111/j.1749-6632.1998.tb10176.x  0.696
1998 Varty GB, Geyer MA. Effects of isolation rearing on startle reactivity, habituation, and prepulse inhibition in male Lewis, Sprague-Dawley, and Fischer F344 rats. Behavioral Neuroscience. 112: 1450-7. PMID 9926827 DOI: 10.1037//0735-7044.112.6.1450  0.622
1998 Paulus MP, Geyer MA, Sternberg E. Differential movement patterns but not amount of activity in unconditioned motor behavior of Fischer, Lewis, and Sprague-Dawley rats. Physiology & Behavior. 65: 601-6. PMID 9877429 DOI: 10.1016/S0031-9384(98)00195-4  0.539
1998 Swerdlow NR, Taaid N, Oostwegel JL, Randolph E, Geyer MA. Towards a cross-species pharmacology of sensorimotor gating: effects of amantadine, bromocriptine, pergolide and ropinirole on prepulse inhibition of acoustic startle in rats. Behavioural Pharmacology. 9: 389-96. PMID 9832924 DOI: 10.1097/00008877-199809000-00002  0.316
1998 Bakshi VP, Geyer MA. Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine Journal of Neuroscience. 18: 8394-8401. PMID 9763482  0.667
1998 Geyer MA. Behavioral studies of hallucinogenic drugs in animals: Implications for schizophrenia research Pharmacopsychiatry. 31: 73-79. PMID 9754837 DOI: 10.1055/S-2007-979350  0.325
1998 Paulus MP, Bakshi VP, Geyer MA. Isolation rearing affects sequential organization of motor behavior in post-pubertal but not pre-pubertal Lister and Sprague-Dawley rats. Behavioural Brain Research. 94: 271-80. PMID 9722278 DOI: 10.1016/S0166-4328(97)00158-7  0.74
1998 Carasso BS, Bakshi VP, Geyer MA. Disruption in prepulse inhibition after alpha-1 adrenoceptor stimulation in rats Neuropharmacology. 37: 401-404. PMID 9681939 DOI: 10.1016/S0028-3908(98)00051-3  0.627
1998 Varty GB, Hauger RL, Geyer MA. Aging effects on the startle response and startle plasticity in Fischer F344 rats. Neurobiology of Aging. 19: 243-51. PMID 9661999 DOI: 10.1016/S0197-4580(98)00053-0  0.611
1998 Swerdlow NR, Geyer MA. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophrenia Bulletin. 24: 285-301. PMID 9613626 DOI: 10.1093/OXFORDJOURNALS.SCHBUL.A033326  0.303
1998 Krebs-Thomson K, Lehmann-Masten V, Naiem S, Paulus MP, Geyer MA. Modulation of phencyclidine-induced changes in locomotor activity and patterns in rats by serotonin. European Journal of Pharmacology. 343: 135-43. PMID 9570460 DOI: 10.1016/S0014-2999(97)01557-4  0.585
1998 Krebs-Thomson K, Paulus MP, Geyer MA. Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 18: 339-51. PMID 9536447 DOI: 10.1016/S0893-133X(97)00164-4  0.576
1998 Bakshi VP, Swerdlow NR, Braff DL, Geyer MA. Reversal of isolation rearing-induced deficits in prepulse inhibition by Seroquel and olanzapine. Biological Psychiatry. 43: 436-45. PMID 9532349 DOI: 10.1016/S0006-3223(97)00246-1  0.694
1998 Swerdlow NR, Varty GB, Geyer MA. Discrepant findings of clozapine effects on prepulse inhibition of startle: is it the route or the rat? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 18: 50-6. PMID 9408918 DOI: 10.1016/S0893-133X(97)00110-3  0.65
1998 Ralph R, Varty G, Kelly M, Grandy D, Low M, Geyer M. 130. Effect of d-amphetamine on prepulse inhibition in dopamine D2 and D4 receptor knockout mice Biological Psychiatry. 43: S39. DOI: 10.1016/S0006-3223(98)90578-9  0.792
1998 Dulawa S, Grandy D, Larson J, Low M, Geyer M. 48. Dopamine D4 receptor-deficient mice exhibit reduced responses to novelty Biological Psychiatry. 43: S15. DOI: 10.1016/S0006-3223(98)90496-6  0.67
1998 Varty G, Paulus M, Braff D, Geyer M. 46. Social enrichment and isolation rearing in the rat: A behavioral comparison Biological Psychiatry. 43: S14. DOI: 10.1016/S0006-3223(98)90494-2  0.713
1997 Dulawa SC, Hen R, Scearce-Levie K, Geyer MA. Serotonin1B receptor modulation of startle reactivity, habituation, and prepulse inhibition in wild-type and serotonin1B knockout mice. Psychopharmacology. 132: 125-34. PMID 9266609 DOI: 10.1007/s002130050328  0.69
1997 Paulus MP, Geyer MA. Environment and unconditioned motor behavior: Influences of drugs and environmental geometry on behavioral organization in rats Psychobiology. 25: 327-337. DOI: 10.3758/Bf03331944  0.545
1997 Geyer MA, Bakshi V, Braff DL, Swerdlow NR. Developmentally specific disruptions of prepulse inhibition: Sensitivity to antipsychotics Schizophrenia Research. 24: 76-77. DOI: 10.1016/S0920-9964(97)82207-4  0.654
1996 Dulawa SC, Geyer MA. Psychopharmacology of prepulse inhibition in mice. The Chinese Journal of Physiology. 39: 139-46. PMID 8955560  0.699
1996 Paulus MP, Geyer MA, Braff DL. Use of methods from chaos theory to quantify a fundamental dysfunction in the behavioral organization of schizophrenic patients. The American Journal of Psychiatry. 153: 714-7. PMID 8615422  0.552
1996 Humby T, Wilkinson L, Robbins T, Geyer M. Prepulses inhibit startle-induced reductions of extracellular dopamine in the nucleus accumbens of rat The Journal of Neuroscience. 16: 2149-2156. DOI: 10.1523/JNEUROSCI.16-06-02149.1996  0.463
1995 Bakshi VP, Geyer MA. Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine Psychopharmacology. 122: 198-201. PMID 8848537 DOI: 10.1007/BF02246096  0.7
1995 Geyer M, Wilkinson L, Humby T, Robbins T. Prepulse inhibition of startle-induced reductions of accumbens dopamine Biological Psychiatry. 37: 634. DOI: 10.1016/0006-3223(95)94560-J  0.374
1994 Wilkinson LS, Killcross SS, Humby T, Hall FS, Geyer MA, Robbins TW. Social isolation in the rat produces developmentally specific deficits in prepulse inhibition of the acoustic startle response without disrupting latent inhibition. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 10: 61-72. PMID 8179795 DOI: 10.1038/npp.1994.8  0.387
1994 Markou A, Matthews K, Overstreet DH, Koob GF, Geyer MA. Flinders resistant hypocholinergic rats exhibit startle sensitization and reduced startle thresholds. Biological Psychiatry. 36: 680-8. PMID 7880937 DOI: 10.1016/0006-3223(94)91177-0  0.402
1994 Paulus MP, Geyer MA, Braff DL. The assessment of sequential response organization in schizophrenic and control subjects. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 18: 1169-85. PMID 7846287 DOI: 10.1016/0278-5846(94)90119-8  0.532
1994 Swerdlow N, Lipska B, Weinberger D, Braff D, Jaskiw G, Geyer M. Startle gating after frontal cortex or hippocampal lesions in adult rats Biological Psychiatry. 35: 707. DOI: 10.1016/0006-3223(94)90987-3  0.385
1993 Paulus MP, Geyer MA. Three independent factors characterize spontaneous rat motor activity. Behavioural Brain Research. 53: 11-20. PMID 8466655 DOI: 10.1016/S0166-4328(05)80262-1  0.539
1993 Geyer MA, Wilkinson LS, Humby T, Robbins TW. Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia Biological Psychiatry. 34: 361-372. PMID 8218603 DOI: 10.1016/0006-3223(93)90180-L  0.451
1993 Paulus MP, Callaway CW, Geyer MA. Quantitative assessment of the microstructure of rat behavior: II. Distinctive effects of dopamine releasers and uptake inhibitors. Psychopharmacology. 113: 187-98. PMID 7855180 DOI: 10.1007/BF02245696  0.561
1993 Paulus MP, Geyer MA. Quantitative assessment of the microstructure of rat behavior: I, f(d), the extension of the scaling hypothesis. Psychopharmacology. 113: 177-86. PMID 7855179 DOI: 10.1007/BF02245695  0.511
1993 Paulus M, Geyer M, Braff D. A simple choice task and complex dynamical methods reveal a fundamental disorganization of response sequences in schiziophrenics Schizophrenia Research. 9: 185. DOI: 10.1016/0920-9964(93)90373-Q  0.474
1992 Rassnick S, Koob GF, Geyer MA. Responding to acoustic startle during chronic ethanol intoxication and withdrawal. Psychopharmacology. 106: 351-8. PMID 1570382 DOI: 10.1007/BF02245417  0.373
1992 Geyer MA, Paulus MP. Multivariate and nonlinear approaches to characterizing drug effects on the locomotor and investigatory behavior of rats. Nida Research Monograph. 124: 203-35. PMID 1470213  0.522
1992 Paulus MP, Geyer MA. The effects of MDMA and other methylenedioxy-substituted phenylalkylamines on the structure of rat locomotor activity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 7: 15-31. PMID 1355968  0.564
1991 Paulus MP, Geyer MA. A scaling approach to find order parameters quantifying the effects of dopaminergic agents on unconditioned motor activity in rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 15: 903-19. PMID 1684875 DOI: 10.1016/0278-5846(91)90018-V  0.56
1991 Paulus MP, Geyer MA. A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants. Psychopharmacology. 104: 6-16. PMID 1679242 DOI: 10.1007/BF02244547  0.549
1991 Paulus MP, Geyer MA, Mandell AJ. Statistical mechanics of a neurobiological dynamical system: The spectrum of local entropies (S(α)) applied to cocaine-perturbed behavior Physica a: Statistical Mechanics and Its Applications. 174: 567-577. DOI: 10.1016/0378-4371(91)90349-H  0.645
1990 Swerdlow NR, Mansbach RS, Geyer MA, Pulvirenti L, Koob GF, Braff DL. Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology. 100: 413-6. PMID 2315438 DOI: 10.1007/BF02244616  0.433
1990 Paulus MP, Geyer MA, Gold LH, Mandell AJ. Application of entropy measures derived from the ergodic theory of dynamical systems to rat locomotor behavior. Proceedings of the National Academy of Sciences of the United States of America. 87: 723-7. PMID 1967830 DOI: 10.1073/Pnas.87.2.723  0.672
1987 Geyer MA, Russo PV, Segal DS, Kuczenski R. Effects of apomorphine and amphetamine on patterns of locomotor and investigatory behavior in rats. Pharmacology, Biochemistry, and Behavior. 28: 393-9. PMID 3685075 DOI: 10.1016/0091-3057(87)90460-6  0.537
1987 Gately PF, Segal DS, Geyer MA. Sequential changes in behavior induced by continuous infusions of amphetamine in rats. Psychopharmacology. 91: 217-20. PMID 3107035 DOI: 10.1007/BF00217066  0.527
1987 Lee EH, Wang FB, Tang YP, Geyer MA. Gabaergic interneurons in the dorsal raphe mediate the effects of apomorphine on serotonergic system. Brain Research Bulletin. 18: 345-53. PMID 2438015  0.429
1986 Gately PF, Segal DS, Geyer MA. The behavioral effects of depletions of brain serotonin induced by 5,7-dihydroxytryptamine vary with time after administration. Behavioral and Neural Biology. 45: 31-42. PMID 3954713 DOI: 10.1016/S0163-1047(86)80003-6  0.523
1986 Geyer MA, Masten VL, Segal DS. Behavioral effects of xylamine-induced depletions of brain norepinephrine: interaction with amphetamine. Behavioural Brain Research. 21: 55-64. PMID 3741596 DOI: 10.1016/0166-4328(86)90060-4  0.509
1986 Swerdlow NR, Geyer MA, Vale WW, Koob GF. Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide. Psychopharmacology. 88: 147-52. PMID 3081925 DOI: 10.1007/BF00652231  0.396
1986 Swerdlow NR, Braff DL, Geyer MA, Koob GF. Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biological Psychiatry. 21: 23-33. PMID 3080033 DOI: 10.1016/0006-3223(86)90005-3  0.444
1985 Gately PF, Poon SL, Segal DS, Geyer MA. Depletion of brain serotonin by 5,7-dihydroxytryptamine alters the response to amphetamine and the habituation of locomotor activity in rats. Psychopharmacology. 87: 400-5. PMID 3936096 DOI: 10.1007/BF00432502  0.523
1984 Geyer MA, Lee EH. Effects of clonidine, piperoxane and locus coeruleus lesion on the serotonergic and dopaminergic systems in raphe and caudate nucleus. Biochemical Pharmacology. 33: 3399-404. PMID 6437408  0.424
1984 Lee EH, Geyer MA. Dopamine autoreceptor mediation of the effects of apomorphine on serotonin neurons. Pharmacology, Biochemistry, and Behavior. 21: 301-11. PMID 6207549  0.432
1984 Lee EH, Geyer MA. Indirect effects of apomorphine on serotoninergic neurons in rats. Neuroscience. 11: 437-42. PMID 6201781  0.436
1983 Lee EH, Geyer MA. Similarities of the effects of apomorphine and 3-PPP on serotonin neurons. European Journal of Pharmacology. 94: 297-303. PMID 6653663  0.432
1982 Geyer MA, Flicker CE, Lee EH. Effects of tactile startle on serotonin content of midbrain raphe neurons in rats. Behavioural Brain Research. 4: 369-76. PMID 7073886  0.439
1982 Lee EH, Geyer MA. Selective effects of apomorphine on dorsal raphe neurons: a cytofluorimetric study. Brain Research Bulletin. 9: 719-25. PMID 6184135  0.438
1980 Lee EH, Geyer MA. Persistent effects of chronic administration of LSD on intracellular serotonin content in rat midbrain. Neuropharmacology. 19: 1005-7. PMID 7422071  0.423
1978 Geyer MA, Petersen LR, Rose GJ, Horwitt DD, Light RK, Adams LM, Zook JA, Hawkins RL, Mandell AJ. The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle. The Journal of Pharmacology and Experimental Therapeutics. 207: 837-47. PMID 731434  0.511
1978 Braff D, Stone C, Callaway E, Geyer M, Glick I, Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 15: 339-43. PMID 693742 DOI: 10.1111/J.1469-8986.1978.Tb01390.X  0.302
1978 Geyer MA, Dawsey WJ, Mandell AJ. Fading: a new cytofluorimetric measure quantifying serotonin in the presence of catecholamines at the cellular level in brain. The Journal of Pharmacology and Experimental Therapeutics. 207: 650-67. PMID 309507  0.503
1976 Geyer MA, Puerto A, Menkes DB, Segal DS, Mandell AJ. Behavioral studies following lesions of the mesolimbic and mesostriatal serotonergic pathways. Brain Research. 106: 257-69. PMID 1276871 DOI: 10.1016/0006-8993(76)91024-6  0.621
1976 Hsu LL, Geyer MA, Mandell AJ. Extrapineal amine N-acetylation in rat brain. Regional and subcellular distribution and enzyme kinetics. Biochemical Pharmacology. 25: 815-9. PMID 938582 DOI: 10.1016/0006-2952(76)90152-0  0.44
1976 Segal DS, Geyer MA. Pre- and post-junctional supersensitivity: differentiation by intraventricular infusions of norepinephrine and methoxamine. Psychopharmacology. 50: 145-8. PMID 188061 DOI: 10.1007/BF00430483  0.511
1976 Geyer MA, Puerto A, Dawsey WJ, Knapp S, Bullard WP, Mandell AJ. Histologic and enzymatic studies of the mesolimbic and mesostriatal serotonergic pathways. Brain Research. 106: 241-56. PMID 6112 DOI: 10.1016/0002-9610(76)90164-1  0.47
1975 Geyer MA, Warbritton JD, Menkes DB, Zook JA, Mandell AJ. Opposite effects of intraventricular serotonin and bufotenin on rat startle responses. Pharmacology, Biochemistry, and Behavior. 3: 687-91. PMID 1187731 DOI: 10.1016/0091-3057(75)90193-8  0.52
1975 Segal DS, Geyer MA, Weiner BE. Strain differences during intraventricular infusion of norepinephrine: possible role of receptor sensitivity. Science (New York, N.Y.). 189: 301-3. PMID 1145205 DOI: 10.1126/Science.1145205  0.504
1975 Geyer MA, Dawsey WJ, Mandell AJ. Differential effects of caffeine, D-amphetamine and methylphenidate on individual raphe cell fluorescence: a microspectrofluorimetric demonstration. Brain Research. 85: 135-9. PMID 1109692 DOI: 10.1016/0006-8993(75)91019-7  0.462
1974 Segal DS, McAllister C, Geyer MA. Ventricular infusion of norepinephrine and amphetamine: direct versus indirect action. Pharmacology, Biochemistry, and Behavior. 2: 79-86. PMID 4857225 DOI: 10.1016/0091-3057(74)90138-5  0.552
1974 Geyer MA, Segal DS. Shock-induced aggression: opposite effects of intraventricularly infused dopamine and norepinephrine. Behavioral Biology. 10: 99-104. PMID 4856062 DOI: 10.1016/S0091-6773(74)91704-0  0.517
1974 Knapp S, Mandell AJ, Geyer MA. Effects of amphetamines on regional tryptophan hydroxylase activity and synaptosomal conversion of tryptophan to 5-hydroxytryptamine in rat brain. The Journal of Pharmacology and Experimental Therapeutics. 189: 676-89. PMID 4843167  0.476
1973 Geyer MA, Segal DS. Differential effects of reserpine and alpha-methyl-P-tyrosine on norepinephrine and dopamine induced behavioral activity. Psychopharmacologia. 29: 131-40. PMID 4709837 DOI: 10.1007/BF00422645  0.507
1973 Korevaar WC, Geyer MA, Knapp S, Hsu LL, Mandell AJ. Regional distribution of 5-methyltetrahydrofolic acid in brain. Nature: New Biology. 245: 244-5. PMID 4518367 DOI: 10.1038/Newbio245244A0  0.442
1972 Geyer MA, Segal DS, Mandell AJ. Effect of intraventricular infusion of dopamine and norepinephrine on motor activity. Physiology & Behavior. 8: 653-8. PMID 5038135 DOI: 10.1016/0031-9384(72)90090-X  0.646
Show low-probability matches.